| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Toxoplasma gondii reactive IgM |
| species reactivity | Toxoplasma gondii |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Toxoplasma gondii IgM Control Serum BC110M
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Toxoplasma gondii IgM Control Serum
- Applications: ELISA
- IgM control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Toxoplasma gondii IgM Control Serum BC110M
| kit |
|---|
| Research area Infectious Disease |
| Storage Store at 2-8°C. |
| Associated products Toxoplasma gondii Avidity Reagent (B110AVID) Toxoplasma gondii Antigen (BA110VS) Toxoplasma gondii IgG Control Serum (BC110G) Toxoplasma gondii IgM Control Serum (BC110M) Toxoplasma gondii IgG ELISA Kit (ESR110G) Toxoplasma gondii IgM ELISA Kit (ESR110M) |
| target relevance |
|---|
| Organism Toxoplasma gondii |
| Protein names Toxoplasma gondii |
| Structure and strains Toxoplasma gondii is a parasitic protozoan (specifically an apicomplexan) that causes toxoplasmosis. Found worldwide, T. gondii is capable of infecting virtually all warm-blooded animals,: 1 but felids are the only known definitive hosts in which the parasite may undergo sexual reproduction. |
| Detection and diagnosis The diagnosis of toxoplasmosis is based on clinical findings and serological investigations. ELISA tests are recommended for the demonstration of IgG and IgM antibodies. Screening for Toxoplasma infections during pregnancy is of significant importance in prenatal care. The transmission of Toxoplasma gondii via the transplacental route has been observed in all stages of pregnancy, although the risk of a prenatal transmission as well as the outcome of infection depends on the stage of pregnancy. The risk of an infection of the unborn child via transplacental transmission is limited to seronegative women who acquire a primary infection during pregnancy. IgM antibodies directed against Toxoplasma gondii can persist for months after infection. Therefore, the determination of the IgG antibody avidity allows for differentiation of primary from past infections. |
Data
FAQ & Publications
Frequently Asked Questions
What is the specific application of the Toxoplasma gondii IgM Control Serum BC110M?
The Toxoplasma gondii IgM Control Serum BC110M is designed for use as a control in ELISA applications, specifically for the detection of IgM antibodies against Toxoplasma gondii in indirect and quantitative assays.
How should the Toxoplasma gondii IgM Control Serum BC110M be stored to maintain its stability?
This control serum should be stored refrigerated at temperatures between 2-8°C to ensure optimal stability and performance.
Is the Toxoplasma gondii IgM Control Serum BC110M compatible with specific diagnostic kits?
Yes, the serum is ready-to-use and pre-diluted for compatibility with SERION ELISA classic and SERION ELISA antigen assays, facilitating straightforward integration into these diagnostic workflows.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC110M protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.